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12.5 (E12.5) (Calver et al., 1998), after the period of motor
neuron production has ended (Nornes and Das, 1974;
Altman and Bayer, 1984). The generation of oligodendro-
cyte precursors from this zone requires ventralization
of the neural tube by notochord- and floor plate±derived
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Sonic hedgehog (Shh) (Orentas and Miller, 1996; Poncet³Department of Neurobiology
et al., 1996; Pringle et al., 1996; Orentas et al., 1999).Stanford University School of Medicine
Lineage tracing studies in vivo have shown that oligoden-Stanford, California 94304
drocytes share a common precursor with neurons and
astrocytes in the spinal cord (Leber et al., 1990), a result
confirmed by clonal analyses of multipotent neural stemSummary
and progenitor cells in vitro (Williams et al., 1991; Temple
and Davis, 1994). However, the time at which motorBasic helix±loop±helix (bHLH) transcription factors
neuron- and oligodendrocyte-producing lineages di-have been identified for neurons and their precursors
verge in the spinal cord is not yet clear. These observa-but not for glial cells. We have identified two bHLH
tions raise the related issues of how the timing andfactors, Oligo1 and Oligo2, that are specifically ex-
spatial restriction of oligodendrocyte production in thepressed in zones of neuroepithelium from which oligo-
spinal cord are achieved and its relationship to the gen-dendrocyte precursors emerge, as well as in the pre-
eration of motor neurons and other ventral neuronalcursors themselves. Expression of Oligo2 in the spinal
subtypes (Tanabe and Jessell, 1996).cord precedes that of platelet-derived growth factor
These questions have been difficult to address be-receptor a (PDGFRa), the earliest known marker of
cause it is not yet clear when ventricular zone cells firstoligodendrocyte precursors, by several days. Ectopic
become determined for an oligodendrocyte fate. Theexpression of Oligo2 in vivo causes ectopic expression
earliest known marker for these cells is PDGFRa (re-of Sox10, an HMG-box transcription factor expressed
viewed by Miller, 1996); however, it is possible that de-in oligodendrocyte and other glial precursors. These
terminative events for the oligodendrocyte lineage havedata identify Oligo genes as the earliest known mark-
already occurred before this receptor is first expressed.ers of oligodendrocyte lineage determination and sug-
Transcription factors have proven to be useful earlygest they play a causal role in this process.
markers of lineage determination in other regions of the
vertebrate nervous system (Lo et al., 1991; Ericson et al.,
1992; reviewed by Tanabe and Jessell, 1996). However,Introduction
there are relatively few transcription factors that mark
the earliest stages of oligodendrocyte developmentOligodendryocytes are the myelinating glial cells of the
(Collarini et al., 1992).central nervous system (CNS). The development of oli-
Basic helix±loop±helix (bHLH) proteins are a family ofgodendrocytes is of considerable importance to an un-
transcriptional regulators that play a key role in cell-derstanding of both neural development and the patho-
type determination in a variety of tissues and organismsgenesis of demyelinating diseases, such as multiple
(reviewed by Garrell and Campuzano, 1991). In the ner-sclerosis. Oligodendrocytes differentiate from bipolar,
vous system, a large number of bHLH factors have beenmigratory precursor cells that arise from specific zones
identified and studied genetically (reviewed by Kage-
of neuroepithelium and then disperse throughout devel-
yama and Nakanishi, 1997; Lee, 1997). These factors
oping gray matter (reviewed by Miller, 1996). A great
include vertebrate homologs of Drosophila proneural
deal is known about the control of proliferation, survival, genes, such as Mash1, the Neurogenins, and NeuroD
and differentiation of oligodendrocyte precursors (re- (Johnson et al., 1990; Lee et al., 1995; Naya et al., 1995;
viewed by Raff, 1989; Barres and Raff, 1994). In contrast, Gradwohl et al., 1996; Ma et al., 1996; Sommer et al.,
much less is known about the factors that control the 1996). For the most part, these genes appear to be
initial commitment of neuroepithelial cells to the oligoden- involved in neuronal rather than glial development; in-
drocyte lineage. deed, no bHLH factor has yet been identified that is
In the developing spinal cord, oligodendrocyte pre- specifically expressed in glial precursors in either the
cursors identified by expression of platelet-derived CNS or the peripheral nervous system (PNS). The gen-
growth factor receptor a (PDGFRa) (Pringle and Rich- eral importance of bHLH factors in cell-type determina-
ardson, 1993; Hall et al., 1996) and other differentiation tion suggested, however, that the identification of such
markers (Yu et al., 1994; Ono et al., 1995; Timsit et al., factors for glial cells would be an important first step in
1995) are generated from a narrow zone in the ventral understanding the early events underlying the determi-
region of the neuroepithelium (Warf et al., 1991; Pringle nation of glial lineages.
et al., 1998; reviewed by Miller, 1996). These precursors Here, we describe the identification and preliminary
begin to emerge in mouse embryos on embryonic day characterization of two novel bHLH factors, called
Oligo1 and Oligo2, that appear to be specifically ex-
pressed in oligodendrocyte precursors throughout the§ To whom correspondence should be addressed (e-mail: c/o
mancusog@cco.caltech.edu). CNS. These genes are also expressed in the restricted
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Figure 1. Sequence of Murine Oligo1 and Oligo2 and Comparison with Other bHLH Factors
(A) Deduced amino acid sequences of Mus musculus Oligo1 and Oligo2. Identical amino acids are boxed. Arrowheads indicate the bHLH domain.
(B) Alignment of the bHLH domains of m.Oligo1 and m.Oligo2 with those of other bHLH factors. Note that while the bHLH domains of Oligo1
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zones of neuroepithelium from which oligodendrocyte Neurogenin 1 (Ma et al., 1996) than it is to other bHLH
factors expressed in the developing nervous system,precursors emerge but are detected considerably earlier
such as Mash1 (Johnson et al., 1990) or dHAND (Srivas-than is PDGFRa. Ectopic expression of Oligo2 in vivo
tava et al., 1995) (Figure 1C). Interestingly, all of theseinduced ectopic expression of Sox10, an HMG-box pro-
neural bHLH factors were more related to each othertein that is another early transcriptional marker of glial
than to Myogenin (Edmondson and Olson, 1989), a rep-lineages (Kuhlbrodt et al., 1998) and that has been func-
resentative of the muscle-specific subfamily of bHLHtionally implicated in myelination in humans (Inoue et
factors (Molkentin and Olson, 1996; Yun and Wold, 1996)al., 1999). Taken together, these data suggest that
(Figure 1C).Oligo1 and Oligo2 are bHLH determination and/or differ-
entiation factors for myelinating glial cells in the CNS.
Oligo2 and Oligo1 Are Specifically and Sequentially
Expressed in the Region of the Spinal CordResults
Neuroepithelium from which
Oligodendrocytes EmergeIdentification of Oligo1 and Oligo2
In situ hybridization analysis of Oligo1 and Oligo2 re-by Database Screening
vealed that they are expressed in the ventral spinal cordWe initially identified Oligo1 and Oligo2 in a database
as early as E9.5 (data not shown). Oligo2 is expressedscreen for as yet uncharacterized bHLH factors that
much more strongly than Oligo1 is at this stage. Bothmight be expressed in the nervous system. Oligo1 and
genes appear to be expressed in the ventral third of theOligo2 sequences were identified as human genomic
developing neural tube but not in the floor plate (Q. Z.sequences present on a single bacterial artificial chro-
and D. J. A., unpublished data). Over the next few days,mosome (BAC) clone derived from chromosome 21q
Oligo2 expression declines in intensity and becomes(see Experimental Procedures). A sequence corre-
progressively restricted to a very narrow band withinsponding to human Oligo2, called RK17, was also de-
the ventral neuroepithelium of the spinal cord (Figureposited by Kuroda et al. (GenBank accession number
2A, arrowhead; data not shown). By E12.0, expressionQ13516). Preliminary in situ hybridization data for these
of Oligo2 in this region has increased (Figure 2E). Oligo1genes were obtained using murine probes generated by
expression declines to undetectable levels by E10.5 andPCR amplification of mouse genomic DNA with primers
reappears in the same narrow zone as Oligo2 at E12.0
based on the human sequences. These data suggested
(Figure 2G). Thus, both genes appear to have early and
that Oligo1 and Oligo2 might be expressed in oligoden-
late phases of expression within the ventral spinal cord.
drocyte-generative zones of the spinal cord (see below). Double-labeling experiments confirmed that these two
To obtain the entire coding sequences of Oligo1 and genes are expressed in the same zone of the neuroepi-
Oligo2, we took advantage of the fact that the coding thelium at E12.0 (Figures 3A and 3D).
sequences of many bHLH factors are contained within The site of expression of these genes was highly remi-
a single exon (e.g., see Guillemot et al., 1993; Fode et niscent of the region from which oligodendrocyte pre-
al., 1998; Ma et al., 1998), and isolated and sequenced cursors have been reported to emerge in the spinal cord
murine genomic clones encoding these genes. The de- (Pringle and Richardson, 1993). We therefore compared
duced amino acid sequences of Oligo1 and Oligo2 are the expression of Oligo2 and Oligo1 to that of several
shown in Figure 1A. The two sequences are virtually other oligodendrocyte precursor markers. A comparison
identical in the bHLH domain, except for the loop region, to PDGFRa indicated that the genes were indeed ex-
which is significantly divergent (78% overall amino acid pressed in an overlapping if not identical domain of
identity in the bHLH domain; Figure 1B). Outside of the the neuroepithelium, except that the bHLH factors were
bHLH region, however, the two sequences are highly expressed earlier than was the growth factor receptor.
divergent (Figure 1A). Both sequences contain strings Oligo2 is expressed about 1±1.5 days before PDGFRa
of repeated amino acids outside of their bHLH domains, mRN is detectable (Figures 2A and 2L), while Oligo1 is
like many other transcription factors. Oligo1 and Oligo2 detected about a day earlier than is PDGFRa (Figures 2G,
have been independently isolated by Rowitch and cowork- arrowhead, and 2L, arrows). Double-label in situ hybrid-
ers in the rat, for which they have been called Olg-1 and ization experiments confirmed that PDGFRa and Oligo
Olg-2, respectively (Lu et al., 2000 [this issue of Neuron]). genes are likely coexpressed in the same cells (Figures
Alignment of the Oligo1 and Oligo2 bHLH domains 3C and 3F, arrows; data not shown). By E14.0, Oligo11
with those of other bHLH factors indicates that these and Oligo21 cells had begun to disperse through the
proteins constitute a distinct subfamily (Figures 1B and gray matter (Figures 2M and 2O, arrow), in a ventral-to-
1C). This subfamily is more closely related to vertebrate dorsal manner similar to that taken by PDGFRa1 cells
bHLH factors homologous to Drosophila ATONAL (Jar- (Figure 2P). At this stage, some Oligo11 and Oligo21
cells still remained in the ventricular zone (Figures 2Mman et al., 1993), such as NeuroD (Lee et al., 1995) and
and Oligo2 are closely related (B), there is little if any sequence homology N- or C-terminal to this region (A) Abbreviations: r, rat, and m,
mouse.
(C) Dendrogram of Oligo1 and Oligo2 bHLH sequences in relation to other bHLH factors. Oligo1 and Oligo2 form a subfamily distinct from
the other bHLH factors, and the neural bHLH factors as a group are distinct from the myogenic bHLH factors represented by Myogenin.
Sources of the indicated sequences are r.KW8 (Kume et al., 1996), NeuroD (Lee et al., 1995), Ngn1 (Ma et al., 1996), Math2 (BartholomaÈ and
Nave, 1994; Shimizu et al., 1995), Mash1 (Franco del Amo et al., 1993; Guillemot and Joyner, 1993), dHAND (Srivastava et al., 1995), and
Myogenin (Edmondson and Olson, 1989). Sequence alignments were performed using the ClustalW program provided with MacVector software,
and the dendrogram was generated using the Pileup Program (GCG).
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Figure 2. Expression of Oligo1 and Oligo2 in the Developing Spinal Cord in Relation to that of Other Oligodendrocyte Precursor Markers
Adjacent or near adjacent sections through the midthoracic spinal cord of mouse embryos at E11.5 (A±D), E12.0 (E±H), E13.0 (I±L), E14.0
(M±P), or E15.5 (Q±T) were hybridized in situ with antisense RNA probes for Oligo1 (C, G, K, O, and S), Oligo2 (A, E, I, M, and Q), Sox10 (B,
F, J, N, and R), and PDGFRa (D, H, L, P, and T). Expression of Oligo2 precedes that of Oligo1 and is first detected at E11.5 ([A], arrowhead).
Oligo1 is first detected at E12.0 ([G], arrowhead). Sox10 expression is faint at E11.5 ([B], arrowhead) but is more prominent at E12.0 ([F],
arrowhead). Note that expression of all three transcription factor markers at E12.0 occurs in a narrow region of the ventricular zone and
precedes that of PDGFRa (E±H and L). Beginning at E13.0, individual cells expressing Oligo1 or Oligo2 can be detected in the gray matter ([I
and K], arrows), similar to what is observed for PDGFRa ([L], arrows). By E15.5, none of the markers are detectably expressed in the ventricular
zone, and all are found in scattered cells throughout the spinal cord (Q±T).
and 2O, arrowheads), however, whereas PDGFRa1 cells We also compared the expression of Oligo2 and
Oligo1 to that of another early transcriptional marker ofwere largely dispersed, and little residual expression in
the ventricular zone was detected (Figure 2P). By E15.5, glial cells, Sox10. Sox10 encodes an HMG-box tran-
scription factor that is expressed in neural crest cellsOligo11 and Oligo21 cells were dispersed throughout
the gray matter, and little or no residual expression in and their derivative PNS glia, as well as in CNS astrocyte
and oligodendrocyte precursors (Kuhlbrodt et al., 1998).the ventricular zone was detected (Figures 2Q and 2S),
a pattern like that of PDGFRa1 cells (Figures 2P and Analysis of Sox10 expression indicated that it was first
detected at about the same time as was expression of2T). Although the number of dispersed Oligo21 cells was
similar to that of the PDGFRa1 cells, the number of Oligo2 and that it preceded the expression of Oligo1 by
about 12 hr and of PDGFRa by about 36 hr (Figures 2B,Oligo11 cells appeared greater than that of PDGFRa1
cells on adjacent sections (Figures 2S and 2T). This 2F, and 2J). Double-labeling experiments indicated that
Oligo genes and Sox10 are likely coexpressed in thedifference may reflect simply a difference in the sensitiv-
ity of our in situ hybridization procedure for detection same cells (Figures 3B, 3E, and 3H; data not shown).
Taken together, these data suggest that Oligo2 andof these two mRNAs; Oligo1 signal was strong after an
overnight development, while that for PDGFRa typically Oligo1 are specifically expressed by progenitors of oli-
godendrocyte precursors in the spinal cord in a sequen-took 2 days to develop. Alternatively, a subset of migra-
tory cells may express Oligo1 but not PDGFRa. tial and overlapping manner (see also Figure 3G, arrows).
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Figure 3. Coexpression of Oligo1 with Oligo2,
Sox10, and PDGFRa
Double-label in situ hybridization was per-
formed on sections through midthoracic spi-
nal cord at the indicated ages with the indi-
cated probes. The color of the lettering of the
probes corresponds to the color of the in situ
hybridization reaction product. (A) and (B),
and (D) and (E), represent low (103 objective)
and high (403 objective) magnification views
of the same fields, respectively. Note that the
domains of the ventricular zone marked by
expression of Oligo1, Oligo2, and Sox10 are
completely overlapping (D and E). Coexpres-
sion of these markers persists at E14.0 in mi-
grating cells dispersed through the gray mat-
ter ([G and H], arrows). At E13.0, individual
cells coexpressing PDGFRa and Oligo1
(arrows) can be seen to emerge from a com-
mon region of the ventricular zone (C and F).
Expression of both Oligo genes continues in PDGFRa1 arrows), in a manner similar to the dispersion of oligo-
dendrocyte precursors visualized using other markersand Sox101 precursors as they migrate away from the
ventricular zone (Figures 3H and 3F, arrows; data not (Hardy and Friedrich, 1996).
These data are generally consistent with the idea thatshown), but Oligo2 appears to be downregulated, while
expression of Oligo1 persists (Figures 2Q and 2S). The Oligo genes are expressed in oligodendrocyte-genera-
tive zones of the neuroepithelium and in oligodendro-overlap of Oligo gene expression with that of PDGFRa
and Sox10 in both the spinal cord and in presumptive cyte precursors in other regions of the CNS. However,
low levels of Oligo2 gene expression were also detectedmigrating oligodendrocyte precursors makes it highly
unlikely that these bHLH genes are expressed in nonoli- in the E13.5 and E14.5 retina, and both genes were
expressed in the olfactory epithelium from E11.5 onwardgodendrocyte lineage cells coincidentally located in the
same region of the ventricular zone as that from which (data not shown). These data suggest that while the
expression of both Oligo genes marks sites of oligoden-oligodendrocytes arise. This conclusion is supported by
in situ hybridization experiments in dissociated primary drocyte precursor formation in the spinal cord and brain,
these genes may also be expressed in developing pe-cultures of P5 optic nerve, which revealed Oligo1 and
Oligo2 expression in elongated, bipolar cells with the ripheral sensory organs, where oligodendrocytes are
not produced. At no time did we detect expression ofcharacteristic morphology of oligodendrocyte precur-
sors (also known as O-2A cells (Raff, 1989) (Figures Oligo genes in developing Schwann cells or their precur-
sors, the myelinating glial cells of the PNS.4A and 4C, arrowheads), as well as in newly formed
oligodendrocytes (Figures 4B and 4D, arrows) but not
in astrocytes or meningeal cells (Figures 4B and 4C,
asterisks). Ectopic Expression of Oligo Genes Causes Ectopic
Expression of Sox10 In Vivo
The timing and location of Oligo gene expression, takenExpression of Oligo Genes in Other Regions
of the CNS together with their homology to other bHLH cell-type
determination factors, suggested that these genesWe also performed a preliminary analysis of Oligo gene
expression in other regions of the developing CNS be- might play a causative role in some aspect of oligoden-
drocyte lineage determination and/or differentiation. Insides the spinal cord. Foci of Oligo gene±expressing
cells were detected in the ventricular zone of the mid- myogenic and neurogenic lineages, forced expression
of bHLH factors has sometimes promoted expression ofbrain and hindbrain (Figures 5A±5F, arrowheads), in re-
gions previously described as sites of oligodendrocyte lineage-specific markers in heterologous cells or tissues
(Davis et al., 1987; Lee et al., 1995; Ma et al., 1996). Weprecursor formation (Hardy and Friedrich, 1996). With
time, Oligo1- and Oligo2-expressing cells became dis- therefore sought to carry out similar gain-of-function
studies for Oligo genes. Efforts to detect precocious orpersed throughout the gray matter (Figures 5G±5L,
Neuron
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Figure 4. Expression of Oligo1 and Oligo2 by
Primary Oligodendrocyte Precursors and Im-
mature Oligodendrocytes
In situ hybridization to primary cultures of P5
rat optic nerve was performed using anti-
sense probes for Oligo1 (A and B) and Oligo2
(C and D). Expression of Oligo1 and Oligo2
was observed in bipolar oligodendrocyte pre-
cursors ([A and C], arrowheads) and in newly
formed oligodendrocytes ([B and D], arrows),
which are distinguishable by their morphol-
ogy from precursors. Neither gene was ex-
pressed by type 1 astrocytes ([B and C], as-
terisks) or meningeal cells (data not shown).
Control cultures hybridized with a mixture of
sense-strand Oligo1 1 Oligo2 probes yielded
no specific signal (data not shown). Scale bar,
10 mm.
expanded expression of oligodendrocyte or oligoden- oligodendrocyte markers in an effort to observe a phe-
notypic effect of Oligo gene misexpression. These mark-drocyte precursor markers (A2B5 and O4) in cultures of
ers included Sox10, PDGFRa, PLP (proteolipid protein),rodent CNS stem cells (Johe et al., 1996) infected with
DM20, MBP (myelin basic protein), and the peripheralretroviral vectors or transfected with expression plas-
glial markers P0 and SMP (Schwann myelin protein)mids encoding either Oligo2 or Oligo1 were unsuccess-
(Dupin et al., 1990; Bhattacharyya et al., 1991). None offul under a variety of culture conditions permissive for
these markers yielded evidence of ectopic oligodendro-oligodendrocyte development (Q. Z. and D. J. A., unpub-
cyte precursor formation or differentiation within thelished data). These data raised the possibility that envi-
neural tube (data not shown). However, in embryos in-ronmental factors present in vivo but not in vitro might
fected with Oligo2-expressing virus we noted that atbe necessary to observe the phenotypic consequences
E7.0, when secondary infection by the replication-com-of Oligo expression. We therefore sought an in vivo
petent virus had spread outside of the neural tube, ap-assay of ectopic Oligo gene expression.
parently ectopic expression of Sox10 could be observedChick embryos have proven to be a useful system for
in the dorsal myotome (data not shown). These datamisexpression of regulatory genes in the developing
suggested that ectopic expression of Oligo genes mightnervous system because retroviruses encoding the
have phenotypic consequences in cells of a mesodermalgene of interest can be conveniently injected into the
lineage.lumen of the neural tube, where they infect proliferating
To confirm and extend these observations, retrovi-neural progenitors in the ventricular zone (Fekete and
ruses encoding Oligo genes (singly or incombination)Cepko, 1993). In the chick, oligodendrocyte precursors
were directly injected into the lumen of the somites atemerge from a restricted zone of the ventral neuroepi-
the epithelial ball stage (HH 10±11) to deliberately infect
thelium, as they do in rodents, beginning on E6.0 (Ham-
paraxial mesodermal precursors. Following such infec-
burger-Hamilton stages [HH] 28±29) (Ono et al., 1995; tions, abundant ectopic expression of Sox10 could be
Timsit et al., 1995; Orentas et al., 1999). Oligodendrocyte detected in both the myotome and in the limb bud muscle
precursors can be detected using O4, an antibody that mass of Oligo2-infected embryos (Figures 6C and 6D).
detects sulfatide and other glycolipids expressed on None of the other markers employed were detected in
the surface of immature and mature oligodendrocytes these ectopic locations, although in some experiments
(Sommer and Schachner, 1981; Ono et al., 1995). In there appeared to be a slightly elevated level of O4
preliminary experiments, we failed to obtain evidence expression in this region (data not shown). Such ectopic
of either premature or expanded expression of O4 in expression of Sox10 was not observed with either
the spinal cords of embryos infected with Oligo2- or Oligo1-expressing virus (Figures 6A and 6B) or a control
Oligo1-encoding retroviruses at E2.0 (HH 10±11), de- virus expressing a nuclear localized luciferase gene (Fig-
spite abundant expression of the retrovirally encoded ures 6G and 6H) (Chen et al., 1998). Coinjection of Oligo1
transgenes (data not shown). and Oligo2-expressing viruses in RCAS(A) and RCAS(B)
backbones was as effective at inducing ectopic Sox10We therefore employed a more extensive battery of
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Figure 5. Expression of Oligo Genes in the Mid- and Hindbrain
Adjacent or near adjacent sections through the region of the medulla (A, B, G, and H), pons (C, D, I, and J), or thalamus (E, F, K, and L) at
E13.0 (A±F) or E14.0 (G±L) were hybridized with Oligo1 or Oligo2 antisense RNA probes. Arrowheads indicate foci of Oligo1 or Oligo2 mRNA
expression in the ventricular zone. Note that at E14.0, cells expressing Oligo1 and Oligo2 have begun to disperse through the gray matter
(e.g., [K], arrows).
as was Oligo2 virus alone (Figures 6E and 6F), indicating 8H, arrows). Although in some cases it appeared that
some MF-201 myocytes coexpressed Sox10, it was diffi-that the lack of effect of Oligo1 on its own was not due
to an inhibitory effect on Sox10 expression. cult to unambiguously discriminate this from labeling in
overlying, closely associated Sox101 cells, which areThese data suggest that ectopic expression of Oligo2
in mesodermal lineage cells can induce Sox10, another likely to be myoblasts (Figure 8G, arrowheads; for tech-
nical reasons, it was not possible to perform in situearly transcription factor marker for oligodendrocyte
precursors, but is insufficient to promote expression of hybridization for Sox10 mRNA with antibody staining for
Pax7). Taken together, these observations suggest thatlater markers. Several pieces of evidence argue that it
is unlikely that the ectopic expression of Sox10 simply ectopic expression of Oligo2 induces ectopic expres-
sion of Sox10 in myoblasts but that this expression isreflects proliferative expansion of neural crest±derived
Sox101 Schwann cell precursors associated with pe- largely extinguished upon differentiation of these cells
to myocytes. The lack of ectopic Sox10 expression inripheral nerves that course through the muscle (Figures
6B and 6H, arrowheads) rather than induction in meso- other tissues expressing ectopic Oligo2, such as skin
(Figure 6, arrows), may reflect the fact that these aredermal cells. First, the cells expressing ectopic Sox10 in
Oligo2-infected limbs (Figures 7C and 7E, arrowheads, sites of secondary infection and therefore may have
had insufficient time to respond by the time of fixation.purple precipitate) were distinct from peripheral nerve-
associated Schwann cell precursors identified by an Alternatively, mesoderm-derived precursors may be es-
pecially permissive for activation of Sox10 by Oligo2.independent marker, HNK-1 (Bronner-Fraser, 1986) (Fig-
ures 7C and 7E, arrows, brown precipitate; see also
Figures 8A, 8C, and 8E, arrows versus arrowheads). Discussion
Second, the Sox101 cells in Oligo2-infected limbs were
distributed in the same regions as cells on near adjacent bHLH transcription factors control the development of
a number of differentiated cell types, including differentsections marked by Pax7, a transcription factor specifi-
cally expressed by myogenic precursors in the limb (Ka- classes of neurons (Kageyama and Nakanishi, 1997;
Lee, 1997), but the members of this family involved inwakami et al., 1997) (Figures 8A and 8C, arrows).
Ectopic expression of Oligo2 in myogenic precursors glial development have not previously been described.
Here, we identify two closely related bHLH factors,did not prevent the differentiation of myogenic lineage
cells, as shown not only by undiminished expression of called Oligo2 and Oligo1, that are specifically expressed
in both oligodendrocyte precursors and in the zone ofthe myoblast marker Pax7 (Figures 8A±8D) but also of
the muscle differentiation marker MF-20 (Figures 8G and the neuroepithelium from which they arise. These genes
Neuron
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Figure 6. Ectopic Expression of Oligo2 in So-
mite-Derived Mesodermal Cells Induces Ec-
topic Sox10 Expression in Chick Embryos In
Vivo
Sections through the limb muscle mass of
embryos infected with replication-competent
retroviruses at E2.0 and harvested at E7.0 are
shown.
(A, C, E, and G) The sections were hybridized
with a probe corresponding to the transgene
expressed by the viruses indicated to the left,
to visualize the extent of infection/expres-
sion. Note that in (E), only Oligo2 hybridization
is shown, although the region illustrated also
expressed Oligo1 (data not shown).
(B, D, F, amd H) Sections adjacent to those
shown in (A), (C), (E), and (G), respectively,
were hybridized with a Sox10 antisense RNA
probe. Note that RCAS-Oligo2 or RCAS-
Oligo1 1 RCAS-Oligo2 caused extensive ec-
topic expression of Sox10 in the muscle mass
(D and F). No such ectopic expression was
observed with RCAS-Oligo1 (B) or RCAS-
luciferase viruses (H). Scattered Sox10-
expressing cells in (B) and (H) are neural crest
derived cells in the subectodermal layer
(arrows) or Schwann cell precursors associ-
ated with peripheral nerve fibers in the muscle
(arrowheads). As shown in Figures 6 and 7,
the ectopic expression of Sox10 does not re-
sult from proliferative expansion of these
Sox101 nerve-associated cells. Note that ex-
panded expression of Sox10 is not seen in
well-infected areas of skin, where individual
Sox101 cells are visible ([C and D], arrows).
are expressed substantially earlier than is PDGFRa, the under culture conditions that are permissive for neuronal
differentiation (Rao et al., 1998; Mujtaba et al., 1999).earliest marker of the oligodendrocyte lineage described
previously (Pringle and Richardson, 1993), and prospec- Whether the induction of Oligo2 occurs in a progenitor
common to neurons and oligodendrocytes or in cellstively identify the region of the neural tube that will gen-
erate oligodendrocytes over 1 day before this process that are already restricted to a glial fate remains to be
determined. Whatever the case, the early expression ofbegins. Ectopic expression of Oligo2 in vivo induces
ectopic expression of Sox10, a glial lineage-specific Oligo2 suggests that the initial events in the specifica-
tion of the oligodendrocyte lineage may have alreadyHMG-box transcription factor (Kuhlbrodt et al., 1998),
in mesodermal lineage cells. Together, these expression occurred at least 1 day before oligodendrocyte precur-
sors can be visualized by expression of PDGFRa.and gain-of-function data suggest that Oligo genes are
likely to play an important role in early stages of oligo- Whatever their lineage relationship to motor neurons,
oligodendrocyte precursors are induced in a specificdendrocyte lineage determination.
zone of the neuroepithelium at a specific time. The fac-
tors controlling this induction are not fully identified.Oligo Genes May Be Involved in a Switch from the
Production of Neurons to Oligodendrocytes Shh is known to be both necessary and sufficient for
oligodendrocyte as well as motor neuron differentiationin the Spinal Cord
Oligodendrocytes arise from the same region of the spi- (Orentas and Miller, 1996; Poncet et al., 1996; Pringle et
al., 1996; Tanabe and Jessell, 1996). Antibody blockingnal cord that generates motor neurons (Sun et al., 1998)
but differentiate after the production of these neurons studies have shown that Shh is required immediately
before the production of oligodendrocyte precursors,is mostly completed. The observation that oligodendro-
cyte precursors can share a common progenitor with when many motor neurons have already differentiated
(Orentas et al., 1999). This late requirement for Shh couldneurons (Leber et al., 1990; Williams et al., 1991) has
been taken to imply that ventricular zone cells in the reflect a role in the induction of Oligo gene expression.
Consistent with this idea, misexpression of Shh dorsallyspinal cord must switch from producing neurons to oli-
godendrocytes (Sun et al., 1998; Orentas et al., 1999). induces ectopic Oligo gene expression in the dorsal
neural tube (Lu et al., 2000). However, it is currently notHowever, apparently glial restricted precursors have re-
cently been isolated from the embryonic rat spinal cord, clear whether this is an indirect consequence of the
effect of Shh to ventralize the neural tube (Ericson et al.,which generates only astrocytes or oligodendrocytes
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Figure 7. Ectopic Sox101 Cells in Oligo2-
Infected Limb Are Distinct from Periph-
eral Nerve-Associated Neural Crest±Derived
Schwann Cells
Limbs of E7.0 embryos injected at E2.0 with
either RCAS-Oligo2 (A, C, and E) or RCAS-
luciferase (B, D, and F) viruses were analyzed
for expression of the retrovirally encoded
transgenes (A and B) or double labeled (C±F)
for Sox10 mRNA (purple) and HNK-1 antibody
staining (brown). (A) and C), and (B) and (D),
are near adjacent sections; (E) and (F) are
higher magnification views of the fields
shown in (C) and (D), respectively. Neural
crest±derived Schwann cells associated with
peripheral nerve fibers in the muscle express
both Sox10 and the HNK-1 epitope ([C±F],
arrows). However the cells expressing ec-
topic Sox10 in the muscle mass ([C and E],
arrowheads) are only purple (i.e., HNK-12)
and therefore are not Schwann cells.
1996) or a more direct effect on Oligo gene expression. been investigated in detail. Here, we show that Sox10
is abundantly expressed in the spinal cord at sites ofWhatever the case, the fact that Shh is required for the
sequential differentiation of both the neuronal and glial oligodendrocyte production and is induced at about the
same time as Oligo2 and before both Oligo1 andlineages indicates that it is unlikely to explain the timing
of oligodendrocyte production. Identification of the fac- PDGFRa. Expression of Sox10 also persists in migratory
oligodendrocyte precursors that express the othertors controlling the temporal onset of Oligo gene expres-
sion may help to shed light on this issue. genes. A dominant mutation in murine Sox10, called
Dom, produces pigmentation defects and agangliogen-Expression of Oligo2 appears restricted to the ventral
spinal cord from the earliest stages we have examined esis of the bowel in heterozygotes (Southard-Smith et
al., 1998), reflecting its early expression in neural crest(E9.5) but is initially expressed in a much broader zone
than it is at later stages (E11.5). A similar narrowing of cells. The embryonic lethality obtained in Dom/Dom ho-
mozygotes precludes an assessment of its role in my-the zone of Oligo1 expression is seen as well, although
this gene is expressed at much lower levels than Oligo2 elination, which occurs postnatally. That Sox10 is func-
tionally important for oligodendrocyte development,is at such early stages. The significance of this early
expression of Oligo genes, particularly that of Oligo2, is however, is suggested by the recent discovery of a hu-
man mutation in the gene that is associated with a CNSnot clear. Although it occurs around the time when motor
neurons are being generated, we did not observe any dysmyelinating disease (Inoue et al., 1999). The fact that
ectopically expressed Oligo2 is able to promote ectopicevidence of ectopic neuronal marker expression in either
the spinal cord or the paraxial mesoderm of embryos expression of Sox10 in vivo therefore provides evidence
of a functional role for Oligo2 in oligodendrocyte lineageectopically expressing Oligo2 (data not shown). One
possibility is that the early phase of Oligo2 expression determination.
The inability of Oligo1 to induce ectopic Sox10 expres-controls the timing of motor neuron generation by tem-
porarily inhibiting such differentiation in the zone where sion is correlated with the fact that it is normally ex-
pressed after Sox10 and Oligo2. The sequential expres-it is expressed. Alternatively, Oligo2 may play a positive
acting role in the differentiation of motor neurons that sion of structurally related bHLH transcription factors is
a characteristic feature of many differentiating lineageshas thus far escaped detection in our functional assays.
(Jan and Jan, 1993); for example, muscle precursors
sequentially express first MyoD (or Myf5) and then Myo-Ectopic Expression of Oligo Genes Promotes
Ectopic Expression of Sox10 genin (Molkentin and Olson, 1996), while precursors of
peripheral sensory neurons first express one of the Neu-Sox10 has been shown to be expressed in glial lineages
in both the CNS and PNS (Kuhlbrodt et al., 1998), but rogenins, followed by one or more members of the Neu-
roD subfamily (Anderson, 1999). Such sequential ex-the precise temporal relationship of its expression to
that of other oligodendrocyte markers has not previously pression of bHLH genes is thought to underly the linked
Neuron
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Figure 8. Ectopic Sox10 Expression in the
Limb Is Compatible with Muscle Differenti-
ation
Sections of limb from embryos injected with
either RCAS-Oligo2 (A, C, E, G, and H) or
RCAS-luciferase (B, D, and F) were pro-
cessed for in situ hybridization with a chick
Sox10 probe (A and B), double labeled with
antibodies to Pax7 (C and D) and HNK-1 (E
and F), or hybridized for Sox10 expression
and counterstained with antibody MF-20, a
muscle-specific marker (G and H). (C) and (E),
and (D) and (F), are images of the same field
viewed with different epifluorescence filters
and are taken from sections near to those
shown in (A) and (B), respectively. Note that
ectopic Sox10 expression is induced in re-
gions of the muscle ([A], arrows) that contain
Pax71 myoblasts ([C], arrows) but not HNK-11
Schwann cell precursors ([E], arrowheads;
see also [B], [D], and [E], arrowheads). Clus-
ters of ectopic Sox101 cells in Oligo2-
infected muscle ([G], arrowheads) are closely
associated with MF-201 myocytes ([G], arrows),
some of which may also express Sox10. The
position and morphology of the Sox101 cells
are similar to those of Sox102 presumptive
myoblasts ([H], arrowheads), which are asso-
ciated with MF-201 myocytes in the contra-
lateral, uninfected limb of an Oligo2-infected
embryo ([H], arrows). Asterisk indicates Sox101
Schwann cell precursors associated with pe-
ripheral nerve fiber (see also [F], arrowheads).
processes of determination and differentiation (Wein- expression over background was sometimes apparent).
That forced expression of Oligo2 fails to recapitulatetraub, 1993). Interestingly, studies of the myogenic
bHLH family suggest that the earlier acting determina- the complete process of oligodendrocyte differentiation,
particularly in cells of a heterologous lineage, is nottion genes, MyoD and Myf5, are more efficient at induc-
ing muscle markers in heterologous cells than is the entirely unexpected. Although MyoD and other muscle-
specific bHLH factors can induce full myogenic differen-downstream differentiation gene Myogenin and that this
difference may be due to a differential ability to alter tiation when ectopically expressed in some heter-
ologous cells (Davis et al., 1987), this activity is notchromatin structure (Gerber et al., 1997). Such a differ-
ence might likewise account for the differential ability observed in all cell types (Weintraub et al., 1989), nor is
it characteristic of all other tissue-specific bHLH factorsof Oligo2 and Oligo1 to activate Sox10 in mesodermal
lineage cells. The fact that Oligo1 is highly homologous that have been studied (see, for example, Johnson et
al., 1992). The ability of Oligo2 to activate Sox10 but notto Oligo2 in the bHLH domain and is expressed in the
same cells as Oligo2 and Sox10 suggests that it may other markers is consistent with the fact that Sox10
is the earliest of these markers to be expressed andplay a role in the maintenance rather than the initiation
of Sox10 expression. suggests that Sox10 may be a direct target of Oligo2.
The failure of Oligo2 to activate later oligodendrocyteNone of the six other markers of oligodendrocytes or
glia that we examined (O4, PLP, DM20, MBP, SMP, and markers may reflect its inability to override the myogenic
determination program of mesodermal cells. In supportP0) were convincingly ectopically activated by Oligo2
in mesodermal cells (although a weak elevation of O4 of this idea, forced expression of the Oligo genes did
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following primary antibodies were used at the indicated dilutions:not prevent activation of the normal myogenic program,
O4 (1:2, hybridoma, ATCC), P0 (1:10, hybridoma, ATCC), anti-SMPas detected by expression of both the myoblast marker
(undiluted, hybridoma, Developmental Studies Hybridoma Bank),Pax7 and the muscle differentiation marker MF-20.
MF-20 (1:10, hybridoma, Developmental Studies Hybridoma Bank),
It may seem paradoxical that ectopic expression of and Pax7 (1:1000, ascites, Developmental Studies Hybridoma
Oligo2 activated ectopic Sox10 expression in mesoder- Bank). Secondary antibodies used were goat-anti-mouse-immuno-
globulin M-FITC (Jackson), goat-anti-mouse-immunoglobulin G-horse-mal lineage cells but not in neural lineage cells, where
radish peroxidase (Chemicon), and goat-anti-mouse-immunoglobulinit normally acts. However, the inability of ectopic Oligo
G-Alexa 568 (Molecular Probes).gene expression to override the endogenous program
Immunohistochemistry after in situ hybridization was performedof neurogenesis in other regions of the neuroepithelium
essentially as described above with the following modification. To
may reflect the tight spatial restriction on the generation better preserve protein antigens, proteinase K digestion in the in
of oligodendrocytes in the spinal cord. Perhaps this lo- situ procedure was lowered from 20 mg/ml for 5 min to 10 mg/ml
for 2 min. Detailed protocols are available upon request.calization involves not only the restricted expression of
presumptive positive regulators of the oligodendrocyte
fate, such as the Oligo genes, but also active inhibition Retroviral Infection Experiments
The murine Oligo1 gene with one Myc epitope tag at the aminoof oligodendrocyte lineage determination in other re-
terminus was cloned into RCASBP(A) (Morgan and Fekete, 1996),gions. If so, then the action of ectopically expressed
and the murine Oligo2 gene with one Myc tag at the amino terminusOligo genes may be prevented by such inhibitors. As
was cloned into the RCASBP(B) (Morgan and Fekete, 1996). The
the mesoderm normally produces neither neurons nor control virus used is an RCASBP(B)-based luciferase with a nuclear
oligodendrocytes, there would be no reason to evolve localization signal and 5 Myc tags at the amino terminus (Chen et
such an inhibitory mechanism, explaining the ability of al., 1998). Viral production was carried out essentially as described
in Perez et al. (1999). Virus was injected unilaterally into somites atectopic Oligo2 expression to activate Sox10 in this non-
the forelimb level of animals at HH 13±15 (somites 15±19) (Christneural tissue. The mechanism of such inhibition will be
and Ordahl, 1995), either singly or in combination. Animals werean interesting topic for further exploration.
harvested at E5.0 or E7.0.
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